Updated on 2025/05/01

写真a

 
SUZUKI Takako
 
Organization
Nagoya University Hospital Pediatrics Assistant Professor
Title
Assistant Professor
External link

Degree 2

  1. Doctor (Medicine) ( 2020.3   Nagoya University ) 

  2. Bachelor(Medicine) ( 2007.3   Nagoya University ) 

Research Interests 12

  1. 小児感染症

  2. 小児肝炎

  3. ウイルス感染症

  4. EBウイルス

  5. 先天性サイトメガロウイルス感染症

  6. 次世代シーケンス

  7. 次世代シーケンス

  8. 小児肝炎

  9. 小児感染症

  10. 先天性サイトメガロウイルス感染症

  11. ウイルス感染症

  12. EBウイルス

Research Areas 2

  1. Life Science / Embryonic medicine and pediatrics

  2. Life Science / Embryonic medicine and pediatrics

Research History 1

  1. 名古屋大学医学部附属病院   小児科学   医員

    2021.4

      More details

Education 1

  1. Nagoya University

    2014.4 - 2020.3

      More details

 

Papers 38

  1. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

    Takako Suzuki, Yoshitaka Sato, Yusuke Okuno, Yuka Torii, Yuto Fukuda, Kazunori Haruta, Makoto Yamaguchi, Yoshiki Kawamura, Asahito Hama, Atsushi Narita, Hideki Muramatsu, Tetsushi Yoshikawa, Yoshiyuki Takahashi, Hiroshi Kimura, Yoshinori Ito, Jun-ichi Kawada

    Journal of Clinical Immunology   Vol. 44 ( 4 )   2024.4

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s10875-024-01701-0

    Scopus

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s10875-024-01701-0/fulltext.html

  2. Association between graft source and response to live-attenuated vaccination in pediatric hematopoietic stem cell transplantation recipients: a single-center retrospective study Open Access

    Takako Suzuki, Jun-ichi Kawada, Eri Nishikawa, Yuka Torii, Kazuhiro Horiba, Suguru Takeuchi, Toshihiko Okumura, Hideki Muramatsu, Yoshiyuki Takahashi, Yoshinori Ito

    BONE MARROW TRANSPLANTATION   Vol. 55 ( 9 ) page: 1872 - 1874   2020.9

     More details

    Authorship:Lead author   Language:English   Publisher:NATURE PUBLISHING GROUP  

    DOI: 10.1038/s41409-020-0867-8

    Web of Science

    Scopus

    researchmap

  3. Comprehensive detection of viruses in pediatric patients with acute liver failure using next-generation sequencing

    Takako Suzuki, Jun-ichi Kawada, Yusuke Okuno, Satoshi Hayano, Kazuhiro Horiba, Yuka Torii, Yoshiyuki Takahashi, Syuichiro Umetsu, Tsuyoshi Sogo, Ayano Inui, Yoshinori Ito

    JOURNAL OF CLINICAL VIROLOGY   Vol. 96   page: 67 - 72   2017.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Background: Pediatric acute liver failure (PALF) is a rare and severe syndrome that frequently requires liver transplantation. Viruses are one of the most frequent causes of this disease, however, pathogenic viruses are not determined in many patients. Recently next-generation sequencing (NGS) has been applied to comprehensively detect pathogens of infectious diseases of unknown etiology.Objectives: To evaluate an NGS-based approach for detecting pathogenic viruses in patients with PALF or acute hepatitis of unknown etiology.Study design: To detect virus-derived DNA and RNA sequences existing in sera/plasma from patients, both DNA and RNA sequencing were performed. First, we validated the ability of NGS to detect viral pathogens in clinical serum/plasma samples, and compared different commercial RNA library preparation methods Then, serum/plasma of fourteen patients with PALF or acute hepatitis of unknown etiology were evaluated using NGS.Results: Among three RNA library preparation methods, Ovation RNA-Seq System V2 had the highest sensitivity to detect RNA viral sequences. Among fourteen patients, sequence reads of torque teno virus, adeno-associated virus, and stealth virus were found in the sera of one patient each, however, the pathophysiological role of these three viruses was not clarified. Significant virus reads were not detected in the remaining 11 patients.Conclusions: This finding might be due to low virus titer in blood at the time of referral or a non-infectious cause might be more frequent. These results suggest an NGS-based approach has potential to detect viral pathogens in clinical samples and would contribute to clarification of the etiology of PALF.

    DOI: 10.1016/j.jcv.2017.10.001

    Web of Science

    Scopus

    researchmap

  4. Plasma Proteomic Profiles of Pediatric Patients With Human Herpesvirus 6B Encephalitis Following Umbilical Cord Blood Transplantation

    Kazunori Haruta, Yuto Fukuda, Hisateru Yamaguchi, Yoshiki Kawamura, Takako Suzuki, Yuka Torii, Atsushi Narita, Hideki Muramatsu, Hiroyuki Kidokoro, Jun Natsume, Yoshiyuki Takahashi, Tetsushi Yoshikawa, Jun‐ichi Kawada

    Journal of Medical Virology   Vol. 97 ( 3 )   2025.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    ABSTRACT

    Human herpesvirus 6B (HHV‐6B) encephalitis is a rare but severe complication of hematopoietic cell transplantation. This study investigated the pathogenesis of HHV‐6B encephalitis by comparing plasma proteomic profiles of four pediatric patients with HHV‐6B encephalitis to three with asymptomatic HHV‐6B reactivation following umbilical cord blood transplantation (UCBT). Plasma proteomic profiling was conducted using liquid chromatography‐mass spectrometry. Overall, 260 proteins were identified and quantified in plasma samples. At the onset of HHV‐6B encephalitis and asymptomatic reactivation, 20 and 24 proteins, respectively, were significantly upregulated compared to their respective pre‐onset levels. Of these, 11 proteins were uniquely upregulated in HHV‐6B encephalitis. S100‐A9 and S100‐A8 were the most and second‐most upregulated proteins in HHV‐6B encephalitis, respectively. Elevated plasma S100A8/A9 heterodimer levels were confirmed via enzyme‐linked immunosorbent assay in three of the four patients with HHV‐6B encephalitis. Pathway analysis identified neutrophil degranulation as the most enriched category among upregulated proteins in HHV‐6B encephalitis. Additionally, proteins related to the protein‐lipid complex remodeling pathway were more prominently upregulated in HHV‐6B encephalitis than in asymptomatic reactivation. Proteomic analysis revealed distinct plasma protein profiles between HHV‐6B encephalitis and asymptomatic HHV‐6B reactivation in pediatric UCBT recipients. The inflammatory response mediated by S100A8/A9 proteins may play a critical role in the pathogenesis of HHV‐6B encephalitis. These findings indicate that proteomic analysis may provide novel insights into the host response to HHV‐6B reactivation and the subsequent development of HHV‐6B encephalitis.

    DOI: 10.1002/jmv.70311

    Scopus

    researchmap

  5. Metagenomic Analysis of Lung Microbiome in Patients With Interstitial Lung Diseases and Sarcoidosis: An Experimental Study Open Access

    Suguru Takeuchi, Jun‐ichi Kawada, Atsushi Suzuki, Koji Sakamoto, Yuto Fukuda, Kazuhiro Horiba, Takako Suzuki, Yuka Torii, Yuichiro Shindo, Yoshinori Ito

    Health Science Reports   Vol. 8 ( 2 )   2025.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    ABSTRACT

    Background and Aims

    Interactions between the lung microbiome and pulmonary epithelium plays a pivotal role in shaping immunity in the lung. Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease (ILD). Some patients with IPF develop episodic acute exacerbations often associated with microbial dysbiosis in the lungs. This study aimed to investigate etiologic agents as well as the lung microbiome in patients with ILDs and sarcoidosis.

    Methods

    This study analyzed 31 patients divided into the IPF (IPF‐stable, n = 12), acute exacerbation of ILDs (AE‐ILDs, n = 6), and sarcoidosis (n = 13) groups. Bronchoalveolar lavage fluid (BALF) samples were analyzed by RNA‐based metagenomic next‐generation sequencing (NGS) on an Illumina platform.

    Results

    In total, 87 pathogens were detected using metagenomic NGS at the genus level. Prevotella, Streptococcus, and Veillonella dominated the BALF microbial communities, and sequence reads of these bacteria were abundant, especially in the sarcoidosis group. Conversely, only a small number of bacterial reads were detected in the AE‐ILDs group, and the overall proportion of microbial composition differed from that of the other groups. No significant difference was found in community diversity (α‐diversity) among the groups, whereas the structural similarity of the microflora (β‐diversity) differed significantly between the AE‐ILDs and sarcoidosis groups.

    Conclusions

    Bacterial sequence reads in BALF were smaller in both the IPF‐stable and AE‐ILD groups than in the sarcoidosis group. Dysbiosis in the lung microbiome has been observed in patients with AE‐ILD and may be related to the progression of inflammation.

    DOI: 10.1002/hsr2.70328

    Open Access

    Scopus

    researchmap

  6. Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection in Japan 2023 Executive Summary

    Ito Y., Morioka I., Takahashi N., Fujioka K., Miura K., Moriuchi H., Morimoto N., Yoshikawa T., Ashina M., Abe S., Imafuku H., Uchida A., Okahashi A., Kakiuchi S., Kakimoto Y., Kawata S., Kawamura Y., Kido T., Kidokoro H., Kozawa K., Samejima T., Suzuki T., Tanimura K., Tomonaga C., Torii Y., Nakanishi M., Nagano N., Nagamatsu T., Narita H., Nishimura K., Nonobe N., Hasegawa Y., Hara K., Hijikata M., Fukuda T., Funato Y., Mimura N., Yamamoto N., Yoshitomi A., Kakei Y., Kodama T., Oka A.

    Pediatric Infectious Disease Journal   Vol. 43 ( 11 ) page: e390 - e396   2024.11

     More details

    Publisher:Pediatric Infectious Disease Journal  

    Congenital cytomegalovirus (cCMV) infection is the most common congenital infection in developed countries. Although a standard therapy has not yet been established, evidence for the management of cCMV infection has been accumulating. The first edition of the “Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection” was published in Japan in 2023. This summary outlines the clinical questions (CQs) in the guidelines, with reference to the Japanese Medical Information Distribution Service Manual. Overall, 20 CQs with statements regarding prenatal risk assessment, prevention and management at diagnosis (CQs 1-1–1-3), diagnosis (CQs 2-1–2-6), treatment (CQs 3-1–3-7) and follow-up requirements (CQs 4-1–4-4) have been discussed. For each statement, the levels of recommendation, evidence and consensus rates were determined. These guidelines will assist in the management of patients with cCMV infection.

    DOI: 10.1097/INF.0000000000004489

    Scopus

  7. Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease

    Kakei Y., Morioka I., Imai T., Itohara K., Yano I., Takahashi N., Yoshikawa T., Moriuchi H., Ito Y., Fujioka K., Oka A., Okahashi A., Nagano N., Hijikata M., Fuwa K., Aoki R., Seimiya A., Imaizumi T., Akimoto T., Hara K., Katayama D., Abe S., Ashina M., Nakasone R., Kyouno Y., Takumi K., Takenaka S., Kakiuchi S., Kakimoto Y., Kozawa K., Funato Y., Miura H., Kawamura Y., Ogata T., Nakashima Y., Kawada J.i., Torii Y., Suzuki T., Fukuda Y., Haruta K., Yamaguchi M., Masaaki T.

    Journal of Infection and Chemotherapy   Vol. 30 ( 10 ) page: 971 - 977   2024.10

     More details

    Publisher:Journal of Infection and Chemotherapy  

    Introduction: Insurance coverage for oral valganciclovir (VGCV) began in Japan in April 2023 on the basis of results, including our clinical trials for symptomatic congenital cytomegalovirus (CMV) disease. The VGCV treatment is available throughout Japan, so clinicians must consider the likelihood of hearing improvement and the possibility of neutropenia before dosing. Materials and methods: We performed a substudy of an investigator-initiated, single-arm, prospective, multicenter, clinical trial in which 24 infants with symptomatic congenital CMV disease were orally administered 16 mg/kg VGCV twice daily for 6 months as an intervention. We examined the infants’ baseline characteristics associated with improved hearing impairment or a severely reduced neutrophil count. Results: Of the 24 patients, 4 had normal hearing on assessment of their ear with the best hearing. Hearing impairment improved in 14 patients and did not respond to VGCV treatment in 6 patients at the 6-month hearing assessment. CMV DNA levels in plasma at baseline were higher in patients in whom hearing did not respond to treatment. A neutrophil count <500/mm3 occurred in 5 (21%) patients for the first 6 weeks and in 8 (33%) patients for the first 6 months. A neutrophil count at screening and the lowest neutrophil count over the 6 months showed the highest correlation (r = 0.477, p = 0.019). Conclusions: Infants with a low plasma viral load at screening tend to have an improvement in hearing impairment. Clinicians should be aware of neutropenia during VGCV treatment particularly in patients with a low neutrophil count during screening.

    DOI: 10.1016/j.jiac.2024.03.006

    Scopus

  8. 次世代シークエンサーを用いた血球貪食性リンパ組織球症の病原体診断

    福田 悠人, 堀場 千尋, 岩田 健一, 山口 慎, 鈴木 高子, 河邉 慎司, 鳥居 ゆか, 川田 潤一

    臨床とウイルス   Vol. 52 ( 3 ) page: 130 - 130   2024.10

     More details

    Language:Japanese   Publisher:日本臨床ウイルス学会  

    researchmap

  9. Association between adeno-associated virus 2 and severe acute hepatitis of unknown etiology in Japanese children Reviewed

    Ken-ichi Iwata, Yuka Torii, Aiko Sakai, Yuto Fukuda, Kazunori Haruta, Makoto Yamaguchi, Takako Suzuki, Yuri Etani, Yoshiyuki Takahashi, Shuichiro Umetsu, Ayano Inui, Ryo Sumazaki, Jun-ichi Kawada

    Journal of Infection and Chemotherapy   Vol. 31 ( 1 )   2024.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.jiac.2024.07.002

    Scopus

    researchmap

  10. Serum proteomic profiles of patients with chronic recurrent multifocal osteomyelitis

    Jun-ichi Kawada, Makoto Yamaguchi, Kazunori Haruta, Yuto Fukuda, Ken-ichi Iwata, Takako Suzuki, Yuka Torii

    Rheumatology   Vol. 64 ( 3 ) page: 1138 - 1146   2024.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Objectives

    Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis.

    Methods

    Proteomic profiling of the sera collected from 11 patients with CRMO (5 patients were in active phase, 6 were in inactive phase) was conducted using liquid chromatography–mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO.

    Results

    Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients.

    Conclusion

    Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.

    DOI: 10.1093/rheumatology/keae301

    Scopus

    researchmap

  11. Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus. International journal

    Yuto Fukuda, Takako Suzuki, Ken-Ichi Iwata, Kazunori Haruta, Makoto Yamaguchi, Yuka Torii, Atsushi Narita, Hideki Muramatsu, Yoshiyuki Takahashi, Jun-Ichi Kawada

    Vaccine   Vol. 42 ( 11 ) page: 2927 - 2932   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The introduction of varicella vaccines into routine pediatric immunization programs has led to a considerable reduction in varicella incidence. However, there have been reports of varicella, herpes zoster, and meningitis caused by the vaccine strain of varicella-zoster virus (VZV), raising concerns. Establishing the relationship between the wild-type and vaccine strains in VZV infections among previously vaccinated individuals is crucial. Differences in the single nucleotide polymorphisms (SNPs) among vaccine strains can be utilized to identify the strain. In this study, we employed nanopore sequencing to identify VZV strains and analyzed clinical samples. METHODS: We retrospectively examined vesicle and cerebrospinal fluid samples from patients with VZV infections. One sample each of the wild-type and vaccine strains, previously identified using allelic discrimination real-time PCR and direct sequencing, served as controls. Ten samples with undetermined VZV strains were included. After DNA extraction, a long PCR targeting the VZV ORF62 region was executed. Nanopore sequencing identified SNPs, allowing discrimination between the vaccine and wild-type strains. RESULTS: Nanopore sequencing confirmed SNPs at previously reported sites (105,705, 106,262, 107,136, and 107,252), aiding in distinguishing between wild-type and vaccine strains. Among the ten unknown samples, nine were characterized as wild strains and one as a vaccine strain. Even in samples with low VZV DNA levels, nanopore sequencing was effective in strain identification. CONCLUSION: This study validates that nanopore sequencing is a reliable method for differentiating between the wild-type and vaccine strains of VZV. Its ability to produce long-read sequences is remarkable, allowing simultaneous confirmation of known SNPs and the detection of new mutations. Nanopore sequencing can serve as a valuable tool for the swift and precise identification of wild-type and vaccine strains and has potential applications in future VZV surveillance.

    DOI: 10.1016/j.vaccine.2024.03.046

    Scopus

    PubMed

    researchmap

  12. MicroRNA expression profiling of urine exosomes in children with congenital cytomegalovirus infection. International journal Open Access

    Yuka Torii, Takako Suzuki, Yuto Fukuda, Kazunori Haruta, Makoto Yamaguchi, Kazuhiro Horiba, Jun-Ichi Kawada, Yoshinori Ito

    Scientific reports   Vol. 14 ( 1 ) page: 5475 - 5475   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Congenital cytomegalovirus (cCMV) infection can damage the central nervous system in infants; however, its prognosis cannot be predicted from clinical evaluations at the time of birth. Urinary exosomes can be used to analyze neuronal damage in neuronal diseases. To investigate the extent of neuronal damage in patients with cCMV, exosomal miRNA expression in the urine was investigated in cCMV-infected infants and controls. Microarray analysis of miRNA was performed in a cohort of 30 infants, including 11 symptomatic cCMV (ScCMV), 7 asymptomatic cCMV (AScCMV), and one late-onset ScCMV cases, and 11 healthy controls (HC). Hierarchical clustering analysis revealed the distinct expression profile of ScCMV. The patient with late-onset ScCMV was grouped into the ScCMV cluster. Pathway enrichment analysis of the target mRNAs differed significantly between the ScCMV and HC groups; this analysis also revealed that pathways related to brain development were linked to upregulated pathways. Six miRNAs that significantly different between groups (ScCMV vs. HC and ScCMV vs. AScCMV) were selected for digital PCR in another cohort for further validation. Although these six miRNAs seemed insufficient for predicting ScCMV, expression profiles of urine exosomal miRNAs can reveal neurological damage in patients with ScCMV compared to those with AcCMV or healthy infants.

    DOI: 10.1038/s41598-024-56106-1

    Open Access

    Scopus

    PubMed

    researchmap

  13. Comparison of Whole Blood and Plasma for Monitoring Cytomegalovirus and Epstein–Barr Virus Open Access

    Fukuda Y., Torii Y., Iwata K.I., Haruta K., Yamaguchi M., Suzuki T., Narita A., Muramatsu H., Ogura Y., Takahashi Y., Ito Y., Kawada J.I.

    New Microbiologica   Vol. 47 ( 1 ) page: 52 - 59   2024.3

     More details

    Publisher:New Microbiologica  

    Monitoring Epstein–Barr virus (EBV) and cytomegalovirus (CMV) infection after transplantation is recommended to enable preemptive therapy. However, the most suitable sample type remains unclear. Patients who underwent hematopoietic stem cell or liver transplantation were included in this study. Viral loads in sequential whole-blood and plasma samples were retrospectively analyzed. EBV DNA was detected more frequently in whole blood (55%) than in plasma (18%). The detection rate of CMV DNA was similar between the two sample types. The correlation of viral loads between the two sample types were 0.515 and 0.688 for EBV and CMV, respectively. Among paired samples in which EBV DNA was detected in whole blood, the plasma EBV detection rate was significantly higher in patients who underwent hematopoietic stem cell transplantation than in those who underwent liver transplantation. The viral DNA load in whole blood and plasma showed similar trends. The EBV detection rate was higher in whole blood, and a high correlation was observed between CMV DNA loads and whole blood and plasma. These results indicate that whole blood is more sensitive for monitoring both EBV and CMV, whereas plasma is a potential alternative sample for monitoring CMV.

    Open Access

    Scopus

  14. Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis. International journal

    Kazunori Haruta, Takako Suzuki, Makoto Yamaguchi, Yuto Fukuda, Yuka Torii, Yoshiyuki Takahashi, Yoshinori Ito, Jun-Ichi Kawada

    Journal of medical virology   Vol. 96 ( 2 ) page: e29450   2024.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Primary Epstein-Barr virus (EBV) infection occasionally causes EBV-infectious mononucleosis (EBV-IM) and EBV-hemophagocytic lymphohistiocytosis (EBV-HLH). Although EBV-IM is mostly mild and self-limiting, EBV-HLH is a life-threatening disease characterized by excessive immune activation. However, the pathogenesis of EBV-HLH is yet to be fully elucidated. A diagnostic biomarker for EBV-HLH is desirable because early diagnosis and treatment are critical for the effective management of patients. In this study, the proteomic profiling of plasma was performed using liquid chromatography-mass spectrometry to identify proteins specific to EBV-IM and EBV-HLH. Furthermore, pathway analysis was performed for the proteins upregulated in patients with EBV-IM and EBV-HLH. Compared to healthy controls, 63 and 18 proteins were upregulated in patients with EBV-IM and EBV-HLH, respectively. Pathway and process enrichment analyses revealed that the complement system was the most enriched category of upregulated proteins in EBV-IM, whereas proteins related to immune effector processes were the most enriched in EBV-HLH. Among the 18 proteins upregulated in EBV-HLH, seven were exclusive to EBV-HLH. These specific proteins were associated with three pathways, and apolipoprotein E was commonly found in all the pathways. Proteomic analysis may provide new insights into the host response to EBV infection and the pathogenesis of EBV-related diseases.

    DOI: 10.1002/jmv.29450

    Scopus

    PubMed

    researchmap

  15. Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19 Open Access

    Kasugai D., Tanaka T., Suzuki T., Ito Y., Nishida K., Ozaki M., Kutsuna T., Yokoyama T., Kaneko H., Ogata R., Matsui R., Goshima T., Hamada H., Ishii A., Kodama Y., Jingushi N., Ishikura K., Kamidani R., Tada M., Okada H., Yamamoto T., Goto Y.

    Frontiers in Immunology   Vol. 15   2024

     More details

    Publisher:Frontiers in Immunology  

    Background: Coronavirus disease 2019 (COVID-19) features a hypercoagulable state, but therapeutic anticoagulation effectiveness varies with disease severity. We aimed to evaluate the dynamics of the coagulation profile and its association with COVID-19 severity, outcomes, and biomarker trajectories. Methods: This multicenter, prospective, observational study included patients with COVID-19 requiring respiratory support. Rotational thromboelastometry findings were evaluated for coagulation and fibrinolysis status. Hypercoagulable status was defined as supranormal range of maximum clot elasticity in an external pathway. Longitudinal laboratory parameters were collected to characterize the coagulation phenotype. Results: Of 166 patients, 90 (54%) were severely ill at inclusion (invasive mechanical ventilation, 84; extracorporeal membrane oxygenation, 6). Higher maximum elasticity (P=0.02) and lower maximum lysis in the external pathway (P=0.03) were observed in severely ill patients compared with the corresponding values in patients on non-invasive oxygen supplementation. Hypercoagulability components correlated with platelet and fibrinogen levels. Hypercoagulable phenotype was associated with favorable outcomes in severely ill patients, while normocoagulable phenotype was not (median time to recovery, 15 days vs. 27 days, P=0.002), but no significant association was observed in moderately ill patients. In patients with severe COVID-19, lower initial C3, minimum C3, CH50, and greater changes in CH50 were associated with the normocoagulable phenotype. Changes in complement components correlated with dynamics of coagulation markers, hematocrit, and alveolar injury markers. Conclusions: While hypercoagulable states become more evident with increasing severity of respiratory disease in patients with COVID-19, normocoagulable phenotype is associated with triggered by alternative pathway activation and poor outcomes.

    DOI: 10.3389/fimmu.2024.1337070

    Open Access

    Scopus

  16. Next-generation sequencing-based detection of Ureaplasma in the gastric fluid of neonates with respiratory distress and chorioamnionitis. International journal Open Access

    Toshihiko Okumura, Kazuhiro Horiba, Nobuyuki Tetsuka, Yoshiaki Sato, Yuichiro Sugiyama, Kazunori Haruta, Makoto Yamaguchi, Takako Suzuki, Yuka Torii, Jun-Ichi Kawada, Tomoo Ogi, Masahiro Hayakawa, Yoshinori Ito

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians   Vol. 36 ( 1 ) page: 2207113 - 2207113   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Respiratory distress is common in neonates admitted to neonatal intensive care units. Additionally, infectious diseases such as intrauterine infections or vertical transmission are important underlying causes of respiratory failure. However, pathogens often cannot be identified in neonates, and there are many cases in which antibacterial drugs are empirically administered. Next-generation sequencing (NGS) is advantageous in that it can detect trace amounts of bacteria that cannot be detected by culturing or bacteria that are difficult to cultivate. However, there are few reports on the diagnosis of infectious diseases using NGS in the neonatal field, especially those targeting respiratory distress. OBJECTIVE: The purpose of our study was to investigate the microorganisms associated with neonatal respiratory distress and to determine whether less invasive collection specimens such as plasma and gastric fluid are useful. METHODS: Neonates were prospectively recruited between January and August 2020 from Nagoya University Hospital. The inclusion criteria were as follows: 1) admission to the neonatal intensive care unit; 2) respiratory distress presentation within 48 h of birth; and 3) suspected infection, collection of blood culture, and administration of antibiotics. Plasma samples and blood cultures were simultaneously collected. Gastric fluid samples were also collected if the patient was not started on enteral nutrition. Information on the patients and their mothers were collected from the medical records. DNA was extracted from 140 µL of plasma and gastric fluid samples. DNA sequencing libraries were prepared, and their quality was analyzed. DNA libraries were sequenced using high-throughput NGS. The NGS data of plasma and gastric fluid samples were analyzed using the metagenomic pipeline PATHDET, which calculated the number of reads assigned to microorganisms and their relative abundance. Putative pathogens were listed. RESULTS: Overall, 30 plasma samples and 25 gastric fluid samples from 30 neonates were analyzed. Microorganism-derived reads of gastric fluid samples were significantly higher than those of plasma samples. Transient tachypnea of the newborn was the most common cause of respiratory distress with 13 cases (43%), followed by respiratory distress syndrome with 7 cases (23%). There were 8 cases (29%) of chorioamnionitis and 7 cases (25%) of funisitis pathologically diagnosed. All blood cultures were negative, and only two gastric fluid cultures were positive for group B Streptococcus (Patient 15) and Candida albicans (Patient 24). Putative pathogens that met the positive criteria for PATHET were detected in four gastric fluid samples, one of which was group B Streptococcus from Patient 15. In the gastric fluid sample of Patient 24, Candida albicans were detected by NGS but did not meet the positive criteria for PATHDET. Cluster analysis of the plasma samples divided them into two study groups, and the indicator genera of each cluster (Phormidium or Toxoplasma) are shown in Figure 1. Clinical findings did not show any significant differences between the two groups. Cluster analysis of the gastric fluid samples divided them into three study groups, and the indicator genera of each cluster (Ureaplasma, Nostoc, and Streptococcus) are shown in Figure 2. The incidence rate of chorioamnionitis was significantly higher in Ureaplasma group than in the other two groups. CONCLUSION: Gastric fluid may be useful for assessing neonatal patients with respiratory distress. To the best of our knowledge, this was the first study to reveal that the presence of Ureaplasma in the gastric fluid of neonates with respiratory distress was associated with chorioamnionitis. The early diagnosis of intra-amniotic infections using gastric fluid and its treatment may change the treatment strategy for neonatal respiratory distress. Screening for Ureaplasma in neonates with respiratory distress may reduce the need for empirical antibiotic administration. Further research is required to confirm these findings.

    DOI: 10.1080/14767058.2023.2207113

    Open Access

    Scopus

    PubMed

    researchmap

  17. Proteomic analysis reveals novel plasma biomarkers for neurological complications in patients with congenital cytomegalovirus infection. International journal

    Makoto Yamaguchi, Takako Suzuki, Hiroyuki Kidokoro, Ken-Ichi Iwata, Yuto Fukuda, Kazunori Haruta, Yuka Torii, Yoshinori Ito, Jun-Ichi Kawada

    Journal of the Pediatric Infectious Diseases Society   Vol. 12 ( 10 ) page: 525 - 533   2023.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Congenital cytomegalovirus (cCMV) infection is a leading cause of nonhereditary neurological complications. When considering antiviral treatment, it is important to differentiate between symptomatic and asymptomatic patients. This study aimed to identify candidate plasma biomarkers for neurological complications of cCMV infection using proteomic analysis. METHODS: This study retrospectively enrolled five patients with symptomatic cCMV infection, four with asymptomatic cCMV infection with isolated sensorineural hearing loss (SNHL), and five with asymptomatic cCMV infection. The plasma samples were collected during neonatal period. The peptides were analyzed using liquid chromatography-mass spectrometry. The concentrations of differentially expressed proteins were validated using an enzyme-linked immunosorbent assay. RESULTS: A total of 456 proteins were identified and quantified. The levels of 80 proteins were significantly different between patients with and without cCMV-related symptoms including isolated SNHL. The levels of 31 proteins were significantly different between patients with and without neuroimaging abnormalities. The plasma concentrations of Fms-related receptor tyrosine kinase 4 in patients with cCMV-related symptoms were significantly higher than those in patients with asymptomatic cCMV infection. Moreover, plasma peptidylprolyl isomerase A levels were significantly higher in patients with neuroimaging abnormalities than in those without. CONCLUSIONS: Proteomic analysis of patients with cCMV infection showed that Fms-related receptor tyrosine kinase 4 and peptidylprolyl isomerase A could be novel diagnostic biomarkers for neurological complications of cCMV infection.

    DOI: 10.1093/jpids/piad074

    Scopus

    PubMed

    researchmap

  18. Utility of nanopore sequencing for detecting pathogens in bronchoalveolar lavage fluid from pediatric patients with respiratory failure Open Access

    Makoto Yamaguchi, Kazuhiro Horiba, Kazunori Haruta, Suguru Takeuchi, Takako Suzuki, Yuka Torii, Shinji Kawabe, Sho Wada, Takanari Ikeyama, Yoshinori Ito, Tomoo Ogi, Jun-ichi Kawada

    Journal of Clinical Virology Plus   Vol. 3 ( 2 ) page: 100154 - 100154   2023.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.jcvp.2023.100154

    Open Access

    Scopus

    researchmap

  19. Association Between NUDT15 R139C Genotype and Neutropenia During Antiviral Therapy in Patients With Congenital Cytomegalovirus Infection Open Access

    Makoto Yamaguchi, Ken-ichi Iwata, Yuto Fukuda, Kazunori Haruta, Takako Suzuki, Yuka Torii, Yoshinori Ito, Jun-ichi Kawada

    Pediatric Infectious Disease Journal   Vol. Publish Ahead of Print ( 7 ) page: E256 - E257   2023.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Ovid Technologies (Wolters Kluwer Health)  

    DOI: 10.1097/inf.0000000000003902

    Scopus

    researchmap

  20. Droplet Digital PCR Development for Adenovirus Load Monitoring in Children after Hematopoietic Stem Cell Transplantation Open Access

    Kazunori Haruta, Suguru Takeuchi, Makoto Yamaguchi, Kazuhiro Horiba, Takako Suzuki, Yuka Torii, Atsushi Narita, Hideki Muramatsu, Yoshiyuki Takahashi, Yoshinori Ito, Jun-ichi Kawada

    The Journal of Molecular Diagnostics   Vol. 25 ( 6 ) page: 403 - 409   2023.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.jmoldx.2023.03.004

    Scopus

    researchmap

  21. ナノポアシークエンサーによる小児中枢神経感染症患者の髄液トランスクリプトーム解析

    堀場 千尋, 鳥居 ゆか, 山口 慎, 春田 一憲, 奥村 俊彦, 鈴木 高子, 河野 好彦, 川田 潤一, 伊藤 嘉規

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集   Vol. 97回・71回   page: O - 147   2023.3

     More details

    Language:Japanese   Publisher:日本感染症学会・日本化学療法学会  

    researchmap

  22. Post-exposure prophylaxis to prevent varicella in immunocompromised children Open Access

    Makoto Yamaguchi, Nobuyuki Tetsuka, Toshihiko Okumura, Kazunori Haruta, Takako Suzuki, Yuka Torii, Jun-ichi Kawada, Yoshinori Ito

    Infection Prevention in Practice   Vol. 4 ( 4 ) page: 100242 - 100242   2022.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.infpip.2022.100242

    Open Access

    Scopus

    researchmap

  23. Performance of Nanopore and Illumina Metagenomic Sequencing for Pathogen Detection and Transcriptome Analysis in Infantile Central Nervous System Infections. International journal Open Access

    Kazuhiro Horiba, Yuka Torii, Yuta Aizawa, Makoto Yamaguchi, Kazunori Haruta, Toshihiko Okumura, Takako Suzuki, Yoshihiko Kawano, Jun-Ichi Kawada, Shinya Hara, Akihiko Saitoh, Christian G Giske, Tomoo Ogi, Yoshinori Ito

    Open forum infectious diseases   Vol. 9 ( 10 ) page: ofac504   2022.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Infantile central nervous system infections (CNSIs) can be life-threatening and cause severe sequelae. However, the causative microorganism remains unknown in >40% of patients with aseptic infections. This study aimed to analyze the metagenome for detection of pathogens and the transcriptome for host immune responses during infection in a single cerebrospinal fluid (CSF) sample using 2 different next-generation sequencing (NGS) platforms, Nanopore and Illumina. Methods: Twenty-eight CNSIs patients (<12 months) were enrolled, and 49 clinical samples (28 CSF and 21 blood) were collected. The DNA extracted from all 49 samples was sequenced using the Illumina sequencer for the detection of pathogens. Extracted RNA was obtained in sufficient quantities from 23 CSF samples and subjected to sequencing on both Nanopore and Illumina platforms. Human-derived reads subtracted during pathogen detection were used for host transcriptomic analysis from both Nanopore and Illumina sequencing. Results: RNA metagenomic sequencing using both sequencing platforms revealed putative viral pathogens in 10 cases. DNA sequencing using the Illumina sequencer detected 2 pathogens. The results of Nanopore and Illumina RNA sequencing were consistent; however, the mapping coverage and depth to the detected pathogen genome of Nanopore RNA sequencing were greater than those of Illumina. Host transcriptomic analysis of Nanopore sequencing revealed highly expressed genes related to the antiviral roles of innate immunity from pathogen-identified cases. Conclusions: The use of Nanopore RNA sequencing for metagenomic diagnostics of CSF samples should help to elucidate both pathogens and host immune responses of CNSI and could shed light on the pathogenesis of these infections.

    DOI: 10.1093/ofid/ofac504

    Open Access

    Scopus

    PubMed

    researchmap

  24. Quantitative assessment of viral load in the blood and urine of patients with congenital cytomegalovirus infection using droplet digital PCR Open Access

    Makoto Yamaguchi, Jun-ichi Kawada, Yuka Torii, Kazunori Haruta, Takako Suzuki, Kazuhiro Horiba, Yoshiyuki Takahashi, Yoshinori Ito

    JOURNAL OF MEDICAL VIROLOGY   Vol. 94 ( 9 ) page: 4559 - 4564   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Congenital cytomegalovirus infection (cCMV) is a common cause of congenital infections, leading to neurodevelopmental sequelae. Real-time quantitative polymerase chain reaction (qPCR) has been widely used for the diagnosis and assessment of cCMV; however, the correlation between CMV DNA load and the severity of cCMV symptoms has been inconclusive. Droplet digital PCR (ddPCR) offers an improvement over the current qPCR methods through the absolute quantification of viral loads. We compared ddPCR and qPCR results for the quantification of CMV DNA in blood and urine specimens from 39 neonates with cCMV (21 symptomatic and 18 asymptomatic). There was no significant difference in blood CMV DNA loads measured by ddPCR and qPCR, with or without any clinical findings. However, developmental delays at 36 months were significantly more frequently observed in patients with high CMV DNA loads (>= 2950 copies/ml), as measured by ddPCR at diagnosis, than in those with lower CMV DNA loads. The association of urine CMV DNA load with symptoms and developmental delay was not observed. CMV DNA loads in the blood might be used as a predictor of developmental outcomes in cCMV patients, and absolute quantitation of viral loads by ddPCR assay could contribute to the standardization of CMV load measurement.

    DOI: 10.1002/jmv.27844

    Open Access

    Web of Science

    Scopus

    researchmap

  25. Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study Open Access

    Yuka Torii, Kazuhiro Horiba, Jun-ichi Kawada, Kazunori Haruta, Makoto Yamaguchi, Takako Suzuki, Hideko Uryu, Naoyuki Kashiwa, Keiji Goishi, Tomoo Ogi, Yoshinori Ito

    BMC INFECTIOUS DISEASES   Vol. 22 ( 1 )   2022.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    Background Congenital human cytomegalovirus (cCMV) infection can cause sensorineural hearing loss and neurodevelopmental disabilities in children. Ganciclovir and valganciclovir (GCV/VGCV) improve long-term audiologic and neurodevelopmental outcomes for patients with cCMV infection; however, antiviral drug resistance has been documented in some cases. Long-read sequencing can be used for the detection of drug resistance mutations. The objective of this study was to develop full-length analysis of UL97 and UL54, target genes with mutations that confer GCV/VGCV resistance using long-read sequencing, and investigate drug resistance mutation in patients with cCMV infection. Methods Drug resistance mutation analysis was retrospectively performed in 11 patients with cCMV infection treated with GCV/VGCV. UL97 and UL54 genes were amplified using blood DNA. The amplicons were sequenced using a long-read sequencer and aligned with the reference gene. Single nucleotide variants were detected and replaced with the reference sequence. The replaced sequence was submitted to a mutation resistance analyzer, which is an open platform for drug resistance mutations. Results Two drug resistance mutations (UL54 V823A and UL97 A594V) were found in one patient. Both mutations emerged after 6 months of therapy, where viral load increased. Mutation rates subsided after cessation of GCV/VGCV treatment. Conclusions Antiviral drug resistance can emerge in patients with cCMV receiving long-term therapy. Full-length analysis of UL97 and UL54 via long-read sequencing enabled the rapid and comprehensive detection of drug resistance mutations.

    DOI: 10.1186/s12879-022-07537-6

    Open Access

    Web of Science

    Scopus

    researchmap

  26. MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing

    Yuka Torii, Jun-Ichi Kawada, Kazuhiro Horiba, Toshihiko Okumura, Takako Suzuki, Yoshinori Ito

    JOURNAL OF NEUROVIROLOGY   Vol. 28 ( 1 ) page: 151 - 157   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Primary human herpesvirus 6 (HHV-6) infection is sometimes accompanied by acute encephalopathy with reduced subcortical diffusion (AED) in immunocompetent children. We investigated exosomal microRNA (miRNA) expression profiles in cerebrospinal fluid (CSF) and sera of patients with HHV-6-associated AED (n = 5) and febrile seizure (FS) (n = 5) using high-throughput sequencing. A total of 176 and 663 miRNAs were identified in CSF and serum exosomes, respectively. Comparative analysis determined that some miRNAs (miR-381-3p, miR-155) were exclusively expressed in the CSF exosomes of AED but not of FS patients, suggesting their potential application as novel diagnostic biomarkers for AED.

    DOI: 10.1007/s13365-022-01058-3

    Web of Science

    Scopus

    researchmap

  27. Next-Generation Sequencing to Detect Pathogens in Pediatric Febrile Neutropenia: A Single-Center Retrospective Study of 112 Cases Open Access

    Kazuhiro Horiba, Yuka Torii, Toshihiko Okumura, Suguru Takeuchi, Takako Suzuki, Jun-Ichi Kawada, Hideki Muramatsu, Yoshiyuki Takahashi, Tomoo Ogi, Yoshinori Ito

    OPEN FORUM INFECTIOUS DISEASES   Vol. 8 ( 11 )   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS INC  

    Background. Febrile neutropenia (FN) is a frequent complication in immunocompromised patients. However, causative microorganisms are detected in only 10% of patients. This study aimed to detect the microorganisms that cause FN using next-generation sequencing (NGS) to identify the genome derived from pathogenic microorganisms in the bloodstream. Here, we implemented a metagenomic approach to comprehensively analyze microorganisms present in clinical samples from patients with FN.Methods. FN is defined as a neutrophil count <500 cells/mu L and fever >= 37.5 degrees C. Plasma/serum samples of 112 pediatric patients with FN and 10 patients with neutropenia without fever (NE) were sequenced by NGS and analyzed by a metagenomic pipeline, PATHDET.Results. The putative pathogens were detected by NGS in 5 of 10 FN patients with positive blood culture results, 15 of 87 FN patients (17%) with negative blood culture results, and 3 of 8 NE patients. Several bacteria that were common in the oral, skin, and gut flora were commonly detected in blood samples, suggesting translocation of the human microbiota to the bloodstream in the setting of neutropenia. The cluster analysis of the microbiota in blood samples using NGS demonstrated that the representative bacteria of each cluster were mostly consistent with the pathogens in each patient.Conclusions. NGS technique has great potential for detecting causative pathogens in patients with FN. Cluster analysis, which extracts characteristic microorganisms from a complex microbial population, may be effective to detect pathogens in minute quantities of microbiota, such as those from the bloodstream.

    DOI: 10.1093/ofid/ofab223

    Open Access

    Web of Science

    Scopus

    researchmap

  28. A Case of Descending Necrotizing Mediastinitis in a Previously Healthy Child Open Access

    Toshihiko Okumura, Nobuyuki Tetsuka, Makoto Yamaguchi, Takako Suzuki, Yuka Torii, Jun-ichi Kawada, Yoshinori Ito

    CASE REPORTS IN PEDIATRICS   Vol. 2021   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:HINDAWI LTD  

    Descending necrotizing mediastinitis (DNM) is a rare complication of oropharyngeal and cervical infection, especially in children. We report a case of DNM secondary to a cervical abscess in a previously healthy 1-year-old boy. The patient presented with redness and swelling of the neck and fever. He was treated with an antimicrobial agent for the diagnosis of cervical lymphadenitis. On the sixth day, a huge mediastinal abscess was found, and he was admitted to the intensive care unit. He was successfully treated with surgical drainage and appropriate antimicrobial therapy. The pus culture isolated multiple bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Although we did not use an antimicrobial agent covering MRSA, the symptoms and test results improved. Washing with drainage was effective. The patient required multidisciplinary treatment, and we collaborated with specialists in other departments. DNM is a severe disease in which team medical care is needed to provide appropriate treatment.</p>

    DOI: 10.1155/2021/3159092

    Open Access

    Web of Science

    researchmap

  29. Pediatric sepsis cases diagnosed with group B streptococcal meningitis using next-generation sequencing: a report of two cases Open Access

    Kazuhiro Horiba, Michio Suzuki, Nobuyuki Tetsuka, Yoshihiko Kawano, Makoto Yamaguchi, Toshihiko Okumura, Takako Suzuki, Yuka Torii, Jun-ichi Kawada, Makoto Morita, Shinya Hara, Tomoo Ogi, Yoshinori Ito

    BMC INFECTIOUS DISEASES   Vol. 21 ( 1 )   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    BackgroundGroup B Streptococcus (GBS) is an important cause of invasive infection in neonates and infants. Cerebrospinal fluid (CSF) findings and culture may not show evidence of infection early in GBS meningitis. Next-generation sequencing (NGS) has the potential to detect microbial genetic material in patients with infectious diseases. We report two cases of infantile sepsis of GBS meningitis with negative results for CSF culture tests, but positive results for NGS analysis.Case presentationPatient 1 was a 22-day-old male infant diagnosed with sepsis and meningitis. His CSF findings showed pleocytosis, decreased glucose, and increased protein levels. However, CSF and blood culture results at admission were negative. He received a total of 3weeks of treatment with ampicillin and cefotaxime, and showed clinical improvement. GBS was detected through NGS analysis of CSF collected at admission. Patient 2 was a 51-day-old male infant with sepsis. CSF findings on admission were normal, and blood and CSF cultures were also negative. Intravenous ampicillin and cefotaxime treatment were initiated. Treatment was de-escalated to ampicillin alone because Enterococcus faecalis was cultured from urine. He was discharged after a total of 1week of antibiotic treatment. Six days after discharge, he was re-hospitalized for sepsis. Blood and CSF cultures were negative, and E. faecalis was again cultured from urine. He received a total of 3weeks of ampicillin treatment for enterococcal-induced nephritis and did not relapse thereafter. NGS pathogen searches were retrospectively performed on both blood and CSF collected at the first and second admission. GBS was detected in the CSF collected at the first admission, but no significant pathogen was detected in the other samples. Inadequate treatment for GBS meningitis at the first admission may have caused the recurrence of the disease.ConclusionInfantile sepsis may present bacterial meningitis that is not diagnosed by either culture testing or CSF findings. NGS analysis for CSF may be useful for confirming the diagnosis of bacterial meningitis.

    DOI: 10.1186/s12879-021-06231-3

    Open Access

    Web of Science

    Scopus

    researchmap

  30. Temporal dynamics of the plasma microbiome in recipients at early post-liver transplantation: a retrospective study Open Access

    Toshihiko Okumura, Kazuhiro Horiba, Hideya Kamei, Suguru Takeuchi, Takako Suzuki, Yuka Torii, Jun-ichi Kawada, Yoshiyuki Takahashi, Yasuhiro Ogura, Tomoo Ogi, Yoshinori Ito

    BMC MICROBIOLOGY   Vol. 21 ( 1 )   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    Background Immunosuppression during liver transplantation (LT) enables the prevention and treatment of organ rejection but poses a risk for severe infectious diseases. Immune modulation and antimicrobials affect the plasma microbiome. Thus, determining the impact of immunosuppression on the microbiome may be important to understand immunocompetence, elucidate the source of infection, and predict the risk of infection in LT recipients. We characterized the plasma microbiome of LT recipients at early post-LT and assessed the association between the microbiome and clinical events. Results In this study, 51 patients who received LT at Nagoya University Hospital from 2016 to 2018 were enrolled. Plasma samples were retrospectively collected at the following time points: 1) within a week after LT; 2) 4 +/- 1 weeks after LT; 3) 8 +/- 1 weeks after LT; and 4) within 2 days after a positive blood culture. A total of 111 plasma samples were analyzed using shotgun next-generation sequencing (NGS) with the PATHDET pipeline. Relative abundance of Anelloviridae, Nocardiaceae, Microbacteriaceae, and Enterobacteriaceae significantly changed during the postoperative period. Microbiome diversity was higher within a week after LT than that at 8 weeks after LT. Antimicrobials were significantly associated with the microbiome of LT recipients. In addition, the proportion of Enterobacteriaceae was significantly increased and the plasma microbiome diversity was significantly lower in patients with acute cellular rejection (ACR) than non-ACR patients. Sequencing reads of bacteria isolated from blood cultures were predominantly identified by NGS in 8 of 16 samples, and human herpesvirus 6 was detected as a causative pathogen in one recipient with severe clinical condition. Conclusions The metagenomic NGS technique has great potential in revealing the plasma microbiome and is useful as a comprehensive diagnostic procedure in clinical settings. Temporal dynamics of specific microorganisms may be used as indirect markers for the determination of immunocompetence and ACR in LT recipients.

    DOI: 10.1186/s12866-021-02154-w

    Open Access

    Web of Science

    Scopus

    researchmap

  31. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT Open Access

    Jun-ichi Kawada, Suguru Takeuchi, Hiroshi Imai, Toshihiko Okumura, Kazuhiro Horiba, Takako Suzuki, Yuka Torii, Kazushi Yasuda, Kyoko Imanaka-Yoshida, Yoshinori Ito

    JOURNAL OF CARDIOLOGY   Vol. 77 ( 2 ) page: 174 - 178   2021.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER  

    Background: Myocarditis is an inflammatory disease of the myocardium, which leads to cardiac dysfunction and heart failure. Previous studies have suggested that complex cross-talk between innate and adaptive immune responses is involved in the pathogenesis of acute myocarditis. Immunohistochemistry is the current standard method for the evaluation of infiltrating immune cells, however, it is difficult to investigate and quantify many immune cell populations using this technique.Methods: Endomyocardial biopsy samples of five pediatric patients with myocarditis were analyzed by cell-type identification by estimating relative subsets of RNA transcript (CIBERSORT), a computational method for quantifying cell fractions from tissue gene expression profiles. CIBERSORT results were then compared with immunohistochemistry analyses.Results: Significant results of immune infiltrate deconvolution were obtained in four patients with fulminant myocarditis by CIBERSORT analysis. Among 22 immune cell types, 19 cell types were detected in one or more patients. Activated NK cells were the most prevalent population in two patients, whereas activated memory CD4(+) T cells and M2 macrophages were the most prevalent population in one patient each. Overall CIBERSORT results were consistent with those of immunohistochemistry, although some discrepancies were observed.Conclusions: Infiltrating immune cell subsets detected by CIBERSORT analysis can reflect the time course of innate and adaptive immune responses in acute myocarditis. CIBERSORT may have the potential to characterize the detail of infiltrating immune cells in myocardial tissues and provide novel insights into the pathogenesis of acute myocarditis. (C) 2020 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.

    DOI: 10.1016/j.jjcc.2020.08.004

    Web of Science

    Scopus

    researchmap

  32. Comprehensive Detection of Candidate Pathogens in the Lower Respiratory Tract of Pediatric Patients With Unexpected Cardiopulmonary Deterioration Using Next-Generation Sequencing Open Access

    Suguru Takeuchi, Jun-ichi Kawada, Kazuhiro Horiba, Makoto Yamaguchi, Toshihiko Okumura, Takako Suzuki, Yuka Torii, Shinji Kawabe, Sho Wada, Takanari Ikeyama, Yoshinori Ito

    PEDIATRIC CRITICAL CARE MEDICINE   Vol. 21 ( 11 ) page: E1026 - E1030   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Objectives:Next-generation sequencing has been applied to the investigation of microorganisms in several clinical settings. We investigated the infectious etiologies in respiratory specimens from pediatric patients with unexpected cardiopulmonary deterioration using next-generation sequencing.Design:Retrospective, single-center, observational study.Setting:Tertiary care, a children's hospital.Subjects:The study enrolled a total of 16 pediatric patients with unexpected cardiopulmonary deterioration who were admitted to the PICU. Ten bronchoalveolar lavage fluid and six transtracheal aspirate samples were analyzed.Interventions:None.Measurements and Main Results:RNA libraries were prepared from specimens and analyzed using next-generation sequencing. One or more bacterial/viral pathogens were detected in the bronchoalveolar lavage fluid or transtracheal aspirate specimens from 10 patients. Bacterial and viral coinfection was considered in four cases. Compared with the conventional culture and viral antigen test results, an additional six bacterial and four viral pathogens were identified by next-generation sequencing. Conversely, among 18 pathogens identified by the conventional methods, nine pathogens were detected by next-generation sequencing. Candidate pathogens (e.g., coxsackievirus A6 and Chlamydia trachomatis) were detected by next-generation sequencing in four of 10 patients in whom no causative pathogen had been identified by conventional methods.Conclusions:Our results suggest that viral and bacterial infections are common triggers in unexpected cardiopulmonary deterioration in pediatric patients. Next-generation sequencing has the potential to contribute to clarification of the etiology of pediatric critical illness.

    DOI: 10.1097/PCC.0000000000002558

    Open Access

    Web of Science

    Scopus

    researchmap

  33. Comprehensive pathogen detection in sera of Kawasaki disease patients by high-throughput sequencing: a retrospective exploratory study Open Access

    Yuka Torii, Kazuhiro Horiba, Satoshi Hayano, Taichi Kato, Takako Suzuki, Jun-ichi Kawada, Yoshiyuki Takahashi, Seiji Kojima, Yusuke Okuno, Tomoo Ogi, Yoshinori Ito

    BMC PEDIATRICS   Vol. 20 ( 1 )   2020.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    Background Kawasaki disease (KD) is an idiopathic systemic vasculitis that predominantly damages coronary arteries in children. Various pathogens have been investigated as triggers for KD, but no definitive causative pathogen has been determined. As KD is diagnosed by symptoms, several days are needed for diagnosis. Therefore, at the time of diagnosis of KD, the pathogen of the trigger may already be diminished. The aim of this study was to explore comprehensive pathogens in the sera at the acute stage of KD using high-throughput sequencing (HTS). Methods Sera of 12 patients at an extremely early stage of KD and 12 controls were investigated. DNA and RNA sequences were read separately using HTS. Sequence data were imported into the home-brew meta-genomic analysis pipeline, PATHDET, to identify the pathogen sequences. Results No RNA virus reads were detected in any KD case except for that of equine infectious anemia, which is known as a contaminant of commercial reverse transcriptase. Concerning DNA viruses, human herpesvirus 6B (HHV-6B, two cases) andAnelloviridae(eight cases) were detected among KD cases as well as controls. Multiple bacterial reads were obtained from KD and controls. Bacteria of the generaAcinetobacter,Pseudomonas,Delfita,Roseomonas, andRhodocyclaceaeappeared to be more common in KD sera than in the controls. Conclusion No single pathogen was identified in serum samples of patients at the acute phase of KD. With multiple bacteria detected in the serum samples, it is difficult to exclude the possibility of contamination; however, it is possible that these bacteria might stimulate the immune system and induce KD.

    DOI: 10.1186/s12887-020-02380-7

    Open Access

    Web of Science

    Scopus

    researchmap

  34. Metagenomic analysis using next-generation sequencing of pathogens in bronchoalveolar lavage fluid from pediatric patients with respiratory failure Open Access

    Suguru Takeuchi, Jun-ichi Kawada, Kazuhiro Horiba, Yusuke Okuno, Toshihiko Okumura, Takako Suzuki, Yuka Torii, Shinji Kawabe, Sho Wada, Takanari Ikeyama, Yoshinori Ito

    SCIENTIFIC REPORTS   Vol. 9 ( 1 )   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Next-generation sequencing (NGS) has been applied in the field of infectious diseases. Bronchoalveolar lavage fluid (BALF) is considered a sterile type of specimen that is suitable for detecting pathogens of respiratory infections. The aim of this study was to comprehensively identify causative pathogens using NGS in BALF samples from immunocompetent pediatric patients with respiratory failure. Ten patients hospitalized with respiratory failure were included. BALF samples obtained in the acute phase were used to prepare DNA-and RNA-sequencing libraries. The libraries were sequenced on MiSeq, and the sequence data were analyzed using metagenome analysis tools. A mean of 2,041,216 total reads were sequenced for each library. Significant bacterial or viral sequencing reads were detected in eight of the 10 patients. Furthermore, candidate pathogens were detected in three patients in whom etiologic agents were not identified by conventional methods. The complete genome of enterovirus D68 was identified in two patients, and phylogenetic analysis suggested that both strains belong to subclade B3, which is an epidemic strain that has spread worldwide in recent years. Our results suggest that NGS can be applied for comprehensive molecular diagnostics as well as surveillance of pathogens in BALF from patients with respiratory infection.

    DOI: 10.1038/s41598-019-49372-x

    Open Access

    Web of Science

    Scopus

    researchmap

  35. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection Open Access

    Yuka Torii, Shigeru Yoshida, Yoichiro Yanase, Takashi Mitsui, Kazuhiro Horiba, Toshihiko Okumura, Suguru Takeuchi, Takako Suzuki, Jun-ichi Kawada, Tomomi Kotani, Mamoru Yamashita, Yoshinori Ito

    BMC PREGNANCY AND CHILDBIRTH   Vol. 19 ( 1 )   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMC  

    BackgroundCytomegalovirus (CMV) is one of the most frequent pathogens for congenital infections. Most cases of congenital CMV infection (cCMV) are asymptomatic at birth, but sensorineural hearing loss (SNHL) or neurodevelopmental delay can appear later in childhood. This prospective study examined the practicability of serological screening for anti-CMV immunoglobulin (Ig) G and anti-CMV IgM in pregnant women.MethodsA total of 11,753 pregnant women were examined for CMV IgG and CMV IgM during the first or second trimester. When IgM was positive, IgG was reevaluated more than two weeks later. When IgG was negative, IgG was reevaluated in the second or third trimester. All neonates from mothers with positive/borderline IgM or IgG seroconversion underwent polymerase chain reaction assay for CMV using urine samples to diagnose cCMV. Levels of IgG and IgM were compared between mothers with and without cCMV. Receiver operating characteristic (ROC) curves for IgM titers were analyzed.ResultsEight of 500 neonates (1.6%) born from mothers with positive IgG and positive IgM, and 3 of 13 neonates (23.1%) born from mothers with IgG seroconversion were diagnosed with cCMV. Neither IgM titers nor IgG titers differed significantly between cCMV and non-cCMV groups. The area under the ROC curve was 0.716 and the optimal cut-off for IgM was 7.28 index (sensitivity=0.625, specificity=0.965, positive predictive value=0.238, negative predictive value=0.993). Titers of IgG were not frequently elevated in pregnant women with positive IgM during the observation period, including in those with cCMV. All 11 cCMV cases were asymptomatic at birth and none had shown SNHL or developmental delay as of the last regular visit (mean age, 40months).ConclusionsSeroconversion of CMV IgG and high-titer IgM during early pregnancy are predictors of cCMV. High IgM titer (>7.28 index) is a predictor despite relatively low sensitivity. Levels of IgG had already plateaued at first evaluation in mothers with cCMV. Maternal screening offered insufficient positive predictive value for diagnosing cCMV, but allowed identifying asymptomatic cCMV cases in an early stage.

    DOI: 10.1186/s12884-019-2360-1

    Open Access

    Web of Science

    Scopus

    researchmap

  36. Identification of potential pathogenic viruses in patients with acute myocarditis using next-generation sequencing

    Suguru Takeuchi, Jun-ichi Kawada, Yusuke Okuno, Kazuhiro Horiba, Takako Suzuki, Yuka Torii, Kazushi Yasuda, Atsushi Numaguchi, Taichi Kato, Yoshiyuki Takahashi, Yoshinori Ito

    JOURNAL OF MEDICAL VIROLOGY   Vol. 90 ( 12 ) page: 1814 - 1821   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Myocarditis is an inflammatory disease of the myocardium and leads to cardiac dysfunction and heart failure. Although viral infections are considered to be the most common etiology of myocarditis, the identification of the causative virus is still challenging. Recently, next-generation sequencing (NGS) has been applied in the diagnosis of infectious diseases. The aim of the current study was to comprehensively analyze potential pathogenic microorganisms using NGS in the sera of patients with myocarditis. Twelve pediatric and five adult patients hospitalized for acute myocarditis were included. Serum samples in the acute phase were obtained and analyzed using NGS to detect pathogen-derived DNA and RNA. Viral sequence reads were detected in 7 (41%) of the 17 myocarditis patients by NGS. Among these patients, detection of Epstein-Barr virus, human parvovirus B19, torque teno virus, and respiratory syncytial virus reads by NGS was consistent with polymerase chain reaction or antigen test results in one patient each. A large number of human pegivirus reads were detected from one patient by RNA sequencing; however, its pathogenicity to human is unknown. Conversely, the number of detected virus-derived reads was small in most cases, and the pathophysiological role of these viruses remains to be clarified. No significant bacterial or fungal reads other than normal bacterial flora was detected. These data indicate that comprehensive detection of virus-derived DNA and RNA using NGS can be useful for the identification of potential pathogenic viruses in myocarditis.We evaluated the utility of NGS to detect potential pathogens of acute myocarditis. Viral sequence reads were obtained in 7 of 17 (41%) cases. A large number of human pegivirus reads was detected from one patient. NGS has the potential to detect the etiologic agent of acute myocarditis.

    DOI: 10.1002/jmv.25263

    Web of Science

    Scopus

    researchmap

  37. Ureteral dilatation detected in magnetic resonance imaging predicts vesicoureteral reflux in children with urinary tract infection Open Access

    Norihiro Murakami, Jun-ichi Kawada, Azumi Watanabe, Toshinao Arakawa, Takamasa Kano, Takako Suzuki, Ryo Tanaka, Daiei Kojima, Yoshihiko Kawano, Shin Hoshino, Hideki Muramatsu, Yoshiyuki Takahashi, Yoshiaki Sato, Masashi Koyama, Jun Natsume

    PLOS ONE   Vol. 13 ( 12 )   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    ObjectiveUrinary tract infection (UTI), one of the most common bacterial infections occurring during infancy and early childhood, is frequently associated with vesicoureteral reflux (VUR). Although several guidelines recommend performing ultrasonography as a screening test, its utility is not adequate and appropriate screening tests are strongly desirable. In this study, we evaluate the use of magnetic resonance imaging (MRI) as a screening test for VUR in children with UTI.MethodsWe prospectively studied 108 patients with suspected UTI between April 2014 and March 2016. UTI was diagnosed on the basis of diffusion-weighted MRI (DW-MRI) and urine culture findings. We measured ureteral dilatation using MRI in 96 patients with UTI and assessed the relationship between ureteral dilatation in MRI and VUR in 46 patients who underwent voiding cystourethrography (VCUG).ResultsAmong 108 patients, 88 and 8 were diagnosed with upper and lower UTI, respectively. Among 46 patients who underwent VCUG, 23 had VUR (14 low grade and 9 high grade). Patients with ureteral dilatation detected on MRI had VUR more frequently than those without ureteral dilatation (any grades VUR, 71% vs. 32%; P = 0.02; high-grade VUR, 38% vs. 2%, P = 0.007). Overall, ureteral dilatation findings on MRI achieved sensitivity 65.2% and specificity 73.9% as a screening test for VUR. In addition, DW-MRI achieved sensitivity 100% and specificity 81.8% in the diagnosis of upper UTI.ConclusionThese findings suggested that MRI is a valuable tool for screening of VUR as well as diagnosis of upper UTI.

    DOI: 10.1371/journal.pone.0209595

    Open Access

    Web of Science

    Scopus

    researchmap

  38. Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing Open Access

    Kazuhiro Horiba, Jun-ichi Kawada, Yusuke Okuno, Nobuyuki Tetsuka, Takako Suzuki, Shotaro Ando, Yasuko Kamiya, Yuka Torii, Tetsuya Yagi, Yoshiyuki Takahashi, Yoshinori Ito

    SCIENTIFIC REPORTS   Vol. 8 ( 1 )   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Bloodstream infection (BSI) is a severe complication in immunocompromised patients. Next-generation sequencing (NGS) allows us to analyze comprehensively and quantitatively all microorganisms present in a clinical sample. Thirty-five pediatric patients (12 with BSI and 23 with suspected BSI/negative blood culture) were enrolled. Plasma/serum samples were used for sequencing and the results were compared with those from blood culture. Sequencing reads of bacteria isolated in blood culture were identified by NGS in all plasma/serum samples at disease onset. Bacteria isolated in blood culture were identical to the dominant bacteria by NGS in 8 of 12 patients. Bacterial reads per million reads of the sequence depth (BR) > 200 and relative importance values of the dominant bacteria (P1) > 0.5 were employed to determine causative pathogens. Causative pathogens were detected using these criteria in 7 of 12 patients with BSI. Additionally, causative bacteria were detected in the plasma/serum at 7 days before disease onset in two patients with catheter-related BSI. Causative pathogens, including virus, were identified in three patients with suspected BSI. Lastly, a total of 62 resistance genes were detected by NGS. In conclusion, NGS is a new method to identify causative microorganisms in BSI and may predict BSI in some patients.

    DOI: 10.1038/s41598-018-22133-y

    Open Access

    Web of Science

    Scopus

    researchmap

▼display all

MISC 27

  1. long-read sequenceによる小児重症呼吸不全患者の網羅的ウイルス検索

    山口 慎, 堀場 千尋, 福田 悠人, 春田 一憲, 武内 俊, 鈴木 高子, 鳥居 ゆか, 河邉 慎司, 伊藤 嘉規, 荻 朋男, 川田 潤一

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 54回   page: 189 - 189   2022.11

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  2. ナノポアシークエンサーによる小児中枢神経感染症の病原微生物検出および宿主遺伝子発現解析

    堀場 千尋, 鳥居 ゆか, 山口 慎, 春田 一憲, 奥村 俊彦, 鈴木 高子, 河野 好彦, 川田 潤一, 原 紳也, 荻 朋男, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 54回   page: 192 - 192   2022.11

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  3. ショートリードおよびロングリードシークエンスを用いた小児中枢神経感染症患者の病原微生物診断

    堀場 千尋, 鳥居 ゆか, 山口 慎, 春田 一憲, 奥村 俊彦, 鈴木 高子, 河野 好彦, 川田 潤一, 伊藤 嘉規, 原 紳也, 荻 朋男

    感染症学雑誌   Vol. 96 ( 臨増 ) page: 120 - 120   2022.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  4. 出生時より呼吸障害を呈した新生児における次世代シークエンスを用いた病原微生物の網羅的検索

    奥村 俊彦, 堀場 千尋, 手塚 宜行, 春田 一憲, 山口 慎, 鈴木 高子, 鳥居 ゆか, 川田 潤一, 伊藤 嘉規, 杉山 裕一朗, 佐藤 義朗, 早川 昌弘, 荻 朋男

    感染症学雑誌   Vol. 96 ( 臨増 ) page: 104 - 104   2022.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  5. Droplet digital PCR法を用いた先天性サイトメガロウイルス感染症患者の全血中および尿中ウイルスDNA量定量法の確立

    山口 慎, 川田 潤一, 春田 一憲, 堀場 千尋, 鈴木 高子, 鳥居 ゆか, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 53回   page: 142 - 142   2021.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  6. 出生時に呼吸障害を呈した新生児における次世代シークエンスを用いた網羅的病原微生物検索

    奥村 俊彦, 堀場 千尋, 手塚 宜行, 佐藤 義朗, 杉山 裕一朗, 春田 一憲, 山口 慎, 鈴木 高子, 鳥居 ゆか, 川田 潤一, 荻 朋男, 早川 昌弘, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 53回   page: 125 - 125   2021.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  7. バルガンシクロビル治療を行った症候性先天性サイトメガロウイルス感染症における薬剤耐性遺伝子の検出

    鳥居 ゆか, 堀場 千尋, 川田 潤一, 春田 一憲, 山口 慎, 奥村 俊彦, 鈴木 高子, 荻 朋男, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 53回   page: 145 - 145   2021.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  8. 間質性肺疾患およびサルコイドーシス患者における肺微生物叢のメタゲノム解析

    武内 俊, 川田 潤一, 堀場 千尋, 鈴木 高子, 鳥居 ゆか, 伊藤 嘉規

    感染症学雑誌   Vol. 95 ( 臨増 ) page: 210 - 210   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  9. 小児ヒトヘルペスウイルス6型関連症における血清・髄液エクソソーム中マイクロRNAの発現解析

    鳥居 ゆか, 山口 慎, 奥村 俊彦, 鈴木 高子, 堀場 千尋, 川田 潤一, 伊藤 嘉規

    日本小児科学会雑誌   Vol. 125 ( 2 ) page: 278 - 278   2021.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  10. CIBERSORTを用いた小児急性心筋炎における炎症性細胞浸潤の網羅的解析

    川田 潤一, 武内 俊, 今井 裕, 堀場 千尋, 山口 慎, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 安田 和志, 今中 恭子, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 52回   page: 188 - 188   2020.11

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  11. 院外心肺停止や予期せぬ呼吸/循環不全を呈した小児患者の下気道検体からの次世代シークエンス法による病原微生物の網羅的検出

    武内 俊, 川田 潤一, 堀場 千尋, 山口 慎, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 52回   page: 190 - 190   2020.11

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  12. 次世代シークエンスデータ解析の効率を向上させる病原微生物予測パイプラインPATHDETの開発

    堀場 千尋, 原 雄一郎, 遠山 美穂, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 川田 潤一, 尾崎 紀夫, 荻 朋男, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 52回   page: 190 - 190   2020.11

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  13. 肝移植後免疫抑制状態における血液中マイクロバイオームダイナミズムの解析

    奥村 俊彦, 堀場 千尋, 武内 俊, 鈴木 高子, 鳥居 ゆか, 川田 潤一, 伊藤 嘉規, 亀井 秀弥, 小倉 靖弘, 荻 朋男

    感染症学雑誌   Vol. 94 ( 臨増 ) page: 300 - 300   2020.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  14. 川崎病症例における血清中微生物メタゲノム解析

    鳥居 ゆか, 堀場 千尋, 早野 聡, 加藤 太一, 鈴木 高子, 川田 潤一, 高橋 義行, 小島 勢二, 伊藤 嘉規

    日本小児科学会雑誌   Vol. 124 ( 2 ) page: 223 - 223   2020.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  15. 妊婦における抗サイトメガロウイルス抗体スクリーニングの有用性

    鳥居 ゆか, 吉田 茂, 柳瀬 陽一郎, 三井 崇, 堀場 千尋, 奥村 俊彦, 武内 俊, 鈴木 高子, 川田 潤一, 小谷 友美, 山下 守, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 51回   page: 219 - 219   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  16. 肝移植後免疫抑制状態における血液中微生物ゲノム分布ダイナミズムの解析

    奥村 俊彦, 堀場 千尋, 亀井 秀弥, 武内 俊, 鈴木 高子, 鳥居 ゆか, 川田 潤一, 小倉 靖弘, 荻 朋男, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 51回   page: 132 - 132   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  17. 次世代シークエンス法による小児呼吸不全患者の気管支肺胞洗浄液からの病原微生物の網羅的検出

    武内 俊, 川田 潤一, 堀場 千尋, 奥野 友介, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 河邉 慎司, 和田 翔, 池山 貴也, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 51回   page: 181 - 181   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  18. 小児発熱性好中球減少症における次世代シークエンス病原微生物診断

    堀場 千尋, 鳥居 ゆか, 原 雄一郎, 嶋田 繭子, 鈴木 高子, 武内 俊, 奥村 俊彦, 川田 潤一, 村松 秀城, 高橋 義行, 荻 朋男, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集   Vol. 51回   page: 196 - 196   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本小児感染症学会  

    researchmap

  19. 小児重症呼吸不全患者の気管支肺胞洗浄液を用いた次世代シークエンス法による病原微生物の網羅的検出 Reviewed

    武内 俊, 川田 潤一, 堀場 千尋, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 奥野 友介, 高橋 義行, 伊藤 嘉規, 河邉 慎司, 池山 貴也

    日本小児科学会雑誌   Vol. 123 ( 8 ) page: 1336 - 1336   2019.8

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  20. 小児重症呼吸器感染症患者の気管支肺胞洗浄液からの次世代シークエンスを用いた病原体検出の有用性

    武内 俊, 川田 潤一, 堀場 千尋, 奥村 俊彦, 鈴木 高子, 鳥居 ゆか, 河邉 慎司, 伊藤 嘉規, 池山 貴也

    感染症学雑誌   Vol. 93 ( 臨増 ) page: 335 - 335   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  21. 次世代シークエンス解析による発熱性好中球減少症の網羅的病原微生物検出

    堀場 千尋, 鳥居 ゆか, 鈴木 高子, 武内 俊, 奥村 俊彦, 川田 潤一, 伊藤 嘉規, 高橋 義行, 嶋田 繭子, 荻 朋男

    感染症学雑誌   Vol. 93 ( 臨増 ) page: 325 - 325   2019.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  22. 次世代シークエンスを用いた急性心筋炎患者の血清検体からの網羅的病原体検出

    武内 俊, 川田 潤一, 奥村 俊彦, 堀場 千尋, 鈴木 高子, 鳥居 ゆか, 安田 和志, 沼口 敦, 加藤 太一, 伊藤 嘉規

    日本小児科学会雑誌   Vol. 123 ( 2 ) page: 315 - 315   2019.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  23. 小児腎移植後の不活化4価インフルエンザワクチン接種の有効性と安全性の検討

    山森 一輝, 岩田 誠子, 柴田 雄介, 宮地 悠江, 鈴木 高子, 柴田 元博, 伊藤 嘉規, 多代 篤史

    日本小児腎不全学会雑誌   Vol. 38   page: 97 - 100   2018.7

     More details

    Language:Japanese   Publisher:日本小児腎不全学会  

    【研究目的】インフルエンザの重症化は小児腎移植患者の生命予後を悪化させるため毎年の予防接種が推奨されている。しかし本邦では小児腎移植患者における不活化4価インフルエンザワクチン(QIV)の有効性や安全性に関する検討は報告されていない。【方法】当院小児科に通院中の腎移植患者で2016~2017シーズンにQIV接種を受けた15症例を対象に接種前後で抗体価を測定し、抗体保有率(SPR)、抗体陽転率(SCR)、幾何平均抗体価(GMT)とその変化率、インフルエンザ診断数、副反応・有害事象を検討した。【結果】全ワクチン株でSPRに有意な上昇はなくSCRも低い水準だった。B型/山形系統のGMTのみ有意な上昇を認めた。重症例は認めず、重篤な副反応・有害事象も認めなかった。【結論】小児腎移植患者へのQIV接種は有効性こそ限定的だが重篤な副反応・有害事象を認めず、安全に接種できると考えられた。(著者抄録)

    researchmap

  24. 小児急性肝不全・重症急性肝炎症例における次世代シークエンスによる網羅的病原微生物同定

    武内 俊, 川田 潤一, 鈴木 高子, 奥村 俊彦, 堀場 千尋, 鳥居 ゆか, 伊藤 嘉規, 奥野 友介, 梅津 守一郎, 十河 剛, 乾 あやの

    日本化学療法学会雑誌   Vol. 66 ( Suppl.A ) page: 297 - 297   2018.4

     More details

    Language:Japanese   Publisher:(公社)日本化学療法学会  

    researchmap

  25. 小児急性肝不全・重症肝炎の網羅的病原ウイルス検出における次世代シーケンサーの応用

    武内 俊, 川田 潤一, 堀場 千尋, 鈴木 高子, 鳥居 ゆか, 梅津 守一郎, 十河 剛, 乾 あやの, 伊藤 嘉規

    日本小児科学会雑誌   Vol. 122 ( 2 ) page: 298 - 298   2018.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  26. 次世代シーケンシングによる血流感染症の微生物ゲノム分布解析と臨床応用

    堀場 千尋, 川田 潤一, 手塚 宜行, 武内 俊, 鈴木 高子, 安藤 将太郎, 神谷 泰子, 鳥居 ゆか, 伊藤 嘉規

    感染症学雑誌   Vol. 91 ( 臨増 ) page: 304 - 304   2017.3

     More details

    Language:Japanese   Publisher:(一社)日本感染症学会  

    researchmap

  27. 小児菌血症患者の病原菌診断における次世代シーケンサーの臨床応用

    堀場 千尋, 川田 潤一, 手塚 宜行, 鈴木 高子, 安藤 将太郎, 神谷 泰子, 鳥居 ゆか, 高橋 義行, 伊藤 嘉規

    日本小児科学会雑誌   Vol. 121 ( 2 ) page: 242 - 242   2017.2

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

▼display all

Presentations 6

  1. EBウイルス関連血球貪食性リンパ組織球症のシングルセルシーケンスによる病態解析

    鈴木 高子, 佐藤 好隆, 鳥居 ゆか, 福田 悠人, 春田 一憲, 山口 慎, 奥野 友介, 濱 麻人, 高橋 義行, 木村 宏, 伊藤 嘉規, 川田 潤一

    日本小児科学会雑誌  2023.2  (公社)日本小児科学会

     More details

    Event date: 2023.2

    Language:Japanese  

    researchmap

  2. シングルセルシーケンスを用いたEBウイルス関連血球貪食性リンパ組織球症の病態解析

    鈴木 高子, 佐藤 好隆, 鳥居 ゆか, 福田 悠人, 春田 一憲, 山口 慎, 奥野 友介, 濱 麻人, 木村 宏, 伊藤 嘉規, 川田 潤一

    日本小児感染症学会総会・学術集会プログラム・抄録集  2022.11  (一社)日本小児感染症学会

     More details

    Event date: 2022.11

    Language:Japanese  

    researchmap

  3. 無症候性先天性サイトメガロウイルス感染症19例の長期フォローアップ

    鈴木 高子, 鳥居 ゆか, 城所 博之, 福田 悠人, 春田 一憲, 山口 慎, 川田 潤一, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集  2022.11  (一社)日本小児感染症学会

     More details

    Event date: 2022.11

    Language:Japanese  

    researchmap

  4. 肝逸脱酵素上昇によりバルガンシクロビル投薬中断を要した症候性先天性サイトメガロウイルス感染症の1例

    鈴木 高子, 鳥居 ゆか, 城所 博之, 春田 一憲, 山口 慎, 川田 潤一, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集  2021.10  (一社)日本小児感染症学会

     More details

    Event date: 2021.10

    Language:Japanese  

    researchmap

  5. 造血細胞移植後小児のキャッチアップ接種と移植細胞ソース別の比較検討

    鈴木 高子, 川田 潤一, 西川 英里, 山口 慎, 奥村 俊彦, 武内 俊, 堀場 千尋, 鳥居 ゆか, 村松 秀城, 高橋 義行, 伊藤 嘉規

    日本小児感染症学会総会・学術集会プログラム・抄録集  2020.11  (一社)日本小児感染症学会

     More details

    Event date: 2020.11

    Language:Japanese  

    researchmap

  6. 次世代シーケンサーによる小児急性肝不全・重症急性肝炎症例からの病原ウイルス検索

    鈴木高子, 川田潤一, 堀場千尋, 梅津守一郎, 十河剛, 奥村俊彦, 武内俊, 鳥居ゆか, 乾あやの, 伊藤嘉規

    第49回日本小児感染症学会  2017.10.22 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 3

  1. 慢性活動性EBウイルス病の病態における感染細胞の役割とシングルセル解析の応用

    Grant number:25K19195  2025.4 - 2027.3

    科学研究費助成事業  若手研究

    鈴木 高子

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

  2. シングルセルシーケンスを用いた小児急性肝不全の病態解析

    Grant number:23K14974  2023.4 - 2025.3

    日本学術振興会  科学研究費助成事業 若手研究  若手研究

    鈴木 高子

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    小児急性肝不全は、生存率50-70%と予後不良な疾患で、約半数が成因不明とされている。成因不明の中にも一部ウイルス性が含まれている可能性が指摘されている。小児急性肝不全の病態にはウイルスによる直接的侵襲の他、宿主の感受性や免疫応答が病態に深く関わっていると考えられる。本研究では次世代シーケンスを用い、これらのウイルス性肝障害の症例の蓄積を図るとともに、近年病態解明に応用されているシングルセルシーケンスを用い、血液中の全免疫細胞の遺伝子発現情報を細胞単位で解析し、他の成因による肝障害と比較することで、ウイルス性肝障害の背景にある免疫応答の異常を解明し、早期診断や、新規治療戦略の検索につなげる。
    小児急性肝不全の病態解明のため、小児急性肝炎および急性肝不全のウイルス定量PCR検査などを用いた起因ウイルス検索を行い、起因ウイルスが同定された症例の末梢血から分離された単核球を用い、シングルセルシーケンス解析を行った。
    これまでに、研究の同意が得られた小児急性肝炎3例(EBウイルス2例、アデノウイルス1例)の末梢血単核球が収集され、内1例(EBウイルス)の急性期および回復期検体のシングルセルシーケンス解析を行った。対照として健常成人2例の末梢血単核球を用いたシングルセルシーケンスと比較検討した。解析を行ったのは計4サンプルで、1サンプルあたり、2,239ー3,403細胞の解析が可能であった。EBウイルス感染症に合併した急性肝炎症例の急性期検体では、TUBA1B+STMN1+CD8+T細胞クラスタの増大を認め、他の文献から、本クラスタは肝組織に由来する可能性が示唆された。また、本症例では、CD8陽性T細胞および単球でⅡ型インターフェロンシグナリングの活性化を認めた。
    現時点では1例の急性肝炎症例の解析にとどまっており、他1例が現在外注でのシーケンス待ちである。他のウイルスに起因する急性肝炎や急性肝不全例での解析データとの比較検討が今後求められる。
    小児急性肝炎例の登録が3例あるものの目標数には達しておらず、小児急性肝不全例の登録が現時点でみられない。症例数が当初予定していた症例数には届いていないが、シングルセルシーケンスによる解析を行った全検体で一定数の末梢血単核球の解析が可能であることが確認された。今後の登録症例の解析につなげたい。
    急性肝不全例の登録、解析のため、研究協力機関に本研究についてあらためて周知するとともに、収集された残る2検体の急性肝炎検体のシングルセルシーケンス解析を行い、病態の中心となっている免疫細胞および各細胞での遺伝子発現調節経路を検討する。得られた解析データをまとめ、学会発表および論文投稿をめざす。

    researchmap

  3. Single-cell RNA sequencing analysis of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

    Grant number:21K20756  2021.8 - 2023.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    Suzuki Takako

      More details

    Authorship:Principal investigator 

    Grant amount:\3120000 ( Direct Cost: \2400000 、 Indirect Cost:\720000 )

    In this study, we applied single-cell RNA sequencing technology to characterize the gene expression of the epidemic cell population of EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and compared it with infectious mononucleosis (EBV-IM), a typical clinical manifestation of primary EBV infection. Three pediatric patients with EBV-HLH, 2 patients with EBV-IM and 2 healthy adults were enrolled, and peripheral blood mononuclear cells were analyzed. A total of 37,405 cells were included. In EBV-HLH, genes involved in type Ⅰ interferon signaling were commonly upregulated in each cell fraction, while monocytes showed robust changes in genes expression in all three EBV-HLH cases. The distinct proliferative CD8+ T cell cluster was recognized in the acute phase of EBV-IM, which cluster was scarce in all three EBV-HLH cases. The gene-expression profile obtained for this cluster is an important finding for understanding the immune response to EBV infection.

    researchmap